Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ken Inaoka

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta|January 22, 2013
Diversity of parasite complex IIShigeharu Harada, Daniel Ken Inaoka, Junko Ohmori, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2018
Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific AntimicrobialsTomokazu Ohishi, Daniel Ken Inaoka, Kiyoshi Kita, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 3, 2009
Crystallization of mitochondrial rhodoquinol-fumarate reductase from the parasitic nematode Ascaris suum with the specific inhibitor flutolanilArihiro Osanai, Shigeharu Harada, Kimitoshi Sakamoto, et al.
ACS Infectious Diseases|November 19, 2024
Accelerating Antimalarial Drug Discovery with a New High-Throughput Screen for Fast-Killing CompoundsTakaya Sakura, Ryuta Ishii, Eri Yoshida, et al.
Data in Brief|December 28, 2020
Effect of the anti-parasitic compounds pyrvinium pamoate and artemisinin in enzymatic and culture assays: Data on the search for new anti-echinococcal drugsShigehiro Enkai, Hirokazu Kouguchi, Daniel Ken Inaoka, et al.
Parasitology International|November 4, 2019
Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cystsShigehiro Enkai, Daniel Ken Inaoka, Hirokazu Kouguchi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 26, 2021
In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in miceShigehiro Enkai, Hirokazu Kouguchi, Daniel Ken Inaoka, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 4, 2008
Screening of detergents for solubilization, purification and crystallization of membrane proteins: a case study on succinate:ubiquinone oxidoreductase from Escherichia coliHironari Shimizu, Coh-ichi Nihei, Daniel Ken Inaoka, et al.
Journal of Biochemistry|May 12, 2012
Crystal structure of mitochondrial quinol-fumarate reductase from the parasitic nematode Ascaris suumHironari Shimizu, Arihiro Osanai, Kimitoshi Sakamoto, et al.
Data in Brief|November 25, 2022
Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against <i>Echinococcus multilocularis</i> protoscolecesHirokazu Kouguchi, Shigehiro Enkai, Hiroyuki Matsuyama, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|January 22, 2013
Diversity of parasite complex IIShigeharu Harada, Daniel Ken Inaoka, Junko Ohmori, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2018
Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific AntimicrobialsTomokazu Ohishi, Daniel Ken Inaoka, Kiyoshi Kita, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 3, 2009
Crystallization of mitochondrial rhodoquinol-fumarate reductase from the parasitic nematode Ascaris suum with the specific inhibitor flutolanilArihiro Osanai, Shigeharu Harada, Kimitoshi Sakamoto, et al.
ACS Infectious Diseases|November 19, 2024
Accelerating Antimalarial Drug Discovery with a New High-Throughput Screen for Fast-Killing CompoundsTakaya Sakura, Ryuta Ishii, Eri Yoshida, et al.
Data in Brief|December 28, 2020
Effect of the anti-parasitic compounds pyrvinium pamoate and artemisinin in enzymatic and culture assays: Data on the search for new anti-echinococcal drugsShigehiro Enkai, Hirokazu Kouguchi, Daniel Ken Inaoka, et al.
Parasitology International|November 4, 2019
Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cystsShigehiro Enkai, Daniel Ken Inaoka, Hirokazu Kouguchi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 26, 2021
In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in miceShigehiro Enkai, Hirokazu Kouguchi, Daniel Ken Inaoka, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 4, 2008
Screening of detergents for solubilization, purification and crystallization of membrane proteins: a case study on succinate:ubiquinone oxidoreductase from Escherichia coliHironari Shimizu, Coh-ichi Nihei, Daniel Ken Inaoka, et al.
Journal of Biochemistry|May 12, 2012
Crystal structure of mitochondrial quinol-fumarate reductase from the parasitic nematode Ascaris suumHironari Shimizu, Arihiro Osanai, Kimitoshi Sakamoto, et al.
Data in Brief|November 25, 2022
Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against <i>Echinococcus multilocularis</i> protoscolecesHirokazu Kouguchi, Shigehiro Enkai, Hiroyuki Matsuyama, et al.
Pageof 8